Stay updated on CTL019 Out of Spec MAP in ALL/DLBCL Clinical Trial
Sign up to get notified when there's something new on the CTL019 Out of Spec MAP in ALL/DLBCL Clinical Trial page.

Latest updates to the CTL019 Out of Spec MAP in ALL/DLBCL Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check29 days agoChange DetectedThe page revision was updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

- Check36 days agoChange DetectedAdded Revision: v3.4.1. Deleted the funding-lapse notice and Revision: v3.4.0.SummaryDifference0.1%

- Check50 days agoChange DetectedAdditions include Show glossary, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0. Deletions include Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.0%

- Check85 days agoChange DetectedThe Locations section was updated to include new site locations across multiple US states, Canada (Ontario and Quebec), and Western Australia, with a revision from v3.3.2 to v3.3.3.SummaryDifference0.9%

Stay in the know with updates to CTL019 Out of Spec MAP in ALL/DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTL019 Out of Spec MAP in ALL/DLBCL Clinical Trial page.